Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +15.1%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 101–150 of 7,500 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07435038	Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS	recruiting	Phase 1 / Phase 2	120	Betta Pharmaceuticals Co., Ltd.INDUSTRY	2	Sep 18, 2026	clinicaltrials
NCT07627191	GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer	recruiting	Early Phase 1	30	University of ArizonaOTHER	1	Sep 18, 2026	clinicaltrials